Hemosiderosis

Common Name(s)

Hemosiderosis

Hemosiderosis is a rare condition where there is too much iron in the body and the blood. This condition can result in long-lasting damage to organs. The liver, lungs and kidneys are usually the most affected organs. Symptoms vary according to the organs affected. Hemosiderosis can be diagnosed with a variety of tests including blood tests, imaging tests, and potentialy biopsies of affected organs, which is where a small needle is used to take a piece of the organ to look at under a microscope. Treatment focuses on removing iron from the body. This may be done with different medications and sometime phlebotomy, or purposefully bleeding.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hemosiderosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hemosiderosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Hemosiderosis" returned 60 free, full-text research articles on human participants. First 3 results:

A physician survey reveals differences in management of idiopathic pulmonary hemosiderosis.
 

Author(s): Chana I C Chin, Shirleen Loloyan Kohn, Thomas G Keens, Monique F Margetis, Roberta M Kato

Journal:

 

Idiopathic pulmonary hemosiderosis (IPH) is a rare disorder of unknown etiology characterized by chronic pulmonary hemorrhage and presents with a triad of anemia, hemoptysis and pulmonary infiltrates. IPH is a diagnosis of exclusion with a variable and disparate clinical course. Despite ...

Last Updated: 20 Aug 2015

Go To URL
Superficial cerebral hemosiderosis in a patient treated with warfarin.
 

Author(s): B M T P Nawasiwatte, A T Sarathchandra, T Rajapakse, P S Gunaratne

Journal: Ceylon Med J. 2014 Dec;59(4):148-9.

 

Last Updated: 5 Jan 2015

Go To URL
Idiopathic pulmonary hemosiderosis - a diagnostic challenge.
 

Author(s): Ilirjana Bakalli, Luljeta Kota, Durim Sala, Ermela Celaj, Elmira Kola, Robert Lluka, Sashenka Sallabanda

Journal:

 

Idiopathic pulmonary hemosiderosis is a rare disorder that can occur at any age and is characterized by the triad of hemoptysis, iron deficiency anemia and diffuse pulmonary infiltrates. The clinical course is exceedingly variable especially in children and a substantial proportion ...

Last Updated: 28 Apr 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Hemosiderosis" returned 3 free, full-text review articles on human participants. First 3 results:

Unexplained childhood anaemia: idiopathic pulmonary hemosiderosis.
 

Author(s): K K Siu, Rever Li, S Y Lam

Journal: Hong Kong Med J. 2015 Apr;21(2):172-4.

 

This report demonstrates pulmonary haemorrhage as a differential cause of anaemia. Idiopathic pulmonary hemosiderosis is a rare disease in children; it is classically described as a triad of haemoptysis, pulmonary infiltrates on chest radiograph, and iron-deficiency anaemia. However, ...

Last Updated: 23 Apr 2015

Go To URL
[Porphyria cutanea tarda, hemosiderosis and hepatocellular carcinoma: report of one case].
 

Author(s): Carolina Whittle, Juan Hepp, Rodolfo Armas, Marcela Schultz

Journal: Rev Med Chil. 2010 May;138(5):581-5.

 

Porphyria cutanea tarda (PCT) is a hereditary or acquired disease. It can be unleashed by iron overload, alcohol, estrogens and other conditions. In these patients, hepatic involvement can be associated to cirrhosis, iron overload or C and B viral infections, that are predisposing ...

Last Updated: 29 Jul 2010

Go To URL
[Idiopathic pulmonary hemosiderosis].
 

Author(s): M Pinto, J Correia, I Leal, A Reis, B Leão, S de Carvalho, C S Sousa

Journal: Acta Med Port. 1996 Jan;9(1):41-4.

 

We report a case of a 23 year-old man admitted to hospital with cough, fever and recurrent episodes of haemoptysis. Laboratory findings, which included a pulmonary biopsy, established the diagnosis of Idiophatic Pulmonary Hemosiderosis (IPH). Despite a number of morphologic, immunologic ...

Last Updated: 10 Jul 1996

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload
 

Status: Not yet recruiting

Condition Summary: Beta-thalassemia Major; Sickle Cell Disease; Iron Hemosiderosis

 

Last Updated: 3 Feb 2012

Go to URL
Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
 

Status: Recruiting

Condition Summary: Iron Overload; Hemochromatosis; Hemosiderosis

 

Last Updated: 24 Nov 2015

Go to URL
Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial Hemosiderosis
 

Status: Not yet recruiting

Condition Summary: Amyloid Cerebral Angiopathy; Alzheimer Disease

 

Last Updated: 6 Apr 2016

Go to URL